Skip to content
Clinical Trials – home
SpainBack to Spain

Clinical trials in Alcoy

7 clinical trials in Alcoy, Spain. Every trial is listed in the EU Clinical Trials Register and updated daily.

SpainOur site in SpainEnsayosClinicos.es(opens in a new tab)
Alcoy at a glance
7
clinical trials
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

7 trials in Alcoy

Open in trial search
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Anastrozole
  • Sponsor:AstraZeneca AB

Breast cancer

Recruiting

Long-Term Study on Early Stage Breast Cancer Patients Using Capecitabine, Gemcitabine, and Paclitaxel

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:Fundacion Grupo Espanol De Investigacion En Cancer De Mama

Breast cancer female

Not yet recruiting

Study of Atezolizumab, Pertuzumab, and Trastuzumab for Patients with HER2 Positive Early High-Risk and Locally Advanced Breast Cancer

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Atezolizumab
  • Sponsor:Fondazione Michelangelo

Study on the Effectiveness of Abemaciclib, Inavolisib, and Giredestrant in Patients with Early HR-positive/HER2-negative Breast Cancer

InvestigationalNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Abemaciclib
  • Sponsor:Medica Scientia Innovation Research S.L.

Breast cancer+7

Not recruiting

Study of sacituzumab govitecan compared to standard therapy in HER2-negative breast cancer patients with high risk of relapse after neoadjuvant treatment

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:GBG Forschungs GmbH

Study on Preventing Blood Clots with Tinzaparin in Patients with Metastatic Colorectal Cancer Starting First-Line Treatment

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Tinzaparin Sodium
  • Sponsor:Grupo Gallego De Investigacion En Tumores Digestivos

Neoplasm malignant

Not recruiting

Study on Atezolizumab and Chemotherapy for Patients with Triple-Negative Breast Cancer

Registered drug
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Atezolizumab
  • Sponsor:NSABP Foundation Inc.

Other cities in Spain

The busiest research cities in the country

All 218 cities in Spain

Clinical research in Alcoy

What the registry says about research in the country

01 Breast Cancer Research

Groundbreaking studies focusing on triple-negative breast cancer and HER2-positive variants, evaluating innovative combination therapies including immunotherapy approaches.

  • Early-stage breast cancer treatments
  • Neoadjuvant chemotherapy combinations
  • Immunotherapy applications

Research aims to improve survival rates through targeted therapeutic strategies.

02 Colorectal Cancer Studies

Investigation of metastatic colorectal cancer management, with particular focus on preventing complications through prophylactic treatments.

  • Thromboembolism prevention
  • First-line treatment optimization
  • Stage IV disease management

Studies emphasize improving patient outcomes in advanced disease stages.

03 Precision Medicine Initiatives

Advanced research utilizing minimal residual disease monitoring and targeted therapies for various breast cancer subtypes.

  • Biomarker-driven treatment
  • Hormone receptor-positive therapy
  • Extended adjuvant approaches

Focus on personalized treatment strategies using molecular diagnostics.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.